WAR CRIMES: Novavax, BARDA, NIH, HHS, & the DoD Join Forces to Unleash Toxic Nanotech Against Americans
Originally posted at Dispatches from Reality, by Scipio Eruditus. dfreality.substack.com
Coordinated malfeasance writ-large…
I — Introduction
Novavax, Inc.’s working relationship with War, Inc. dates back to at least 2011, when BARDA awarded the company with $97 million in grants to fight “the seasonal influenza”. Like AstraZeneca, IBM, or Lockheed-Martin, Novavax is located in the outskirts of D.C. in the suburb of Gaithersburg, Maryland. Long before Novavax, Inc. was ever selected to produce the DoD’s transhumanist potions, it was involved in the highly dubious Ebola vaccine trials (yet another well-documented fear-porn campaign). Its ties with one of the most notoriously corrupt pharmaceutical companies in America, Emergent Biosolutions, further draws the credibility of Novavax into question.
Despite not bringing a single vaccine to market in their 33-years as a company (33, seriously??), the Trump Administration decided to award Novavax, Inc. with the largest of Operation Warp Speed’s many contracts (emphasis mine):
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) today jointly announced a $1.6 billion agreement with Novavax, Inc. of Gaithersburg, Maryland, to demonstrate commercial-scale manufacturing of the company’s COVID-19 investigational vaccine. By funding this manufacturing effort, the federal government will own the 100 million doses of investigational vaccine expected to result from the demonstration projects.
— US Department of Defense, July 7th, 2020
Just like Pfizer, Moderna, and J&J, the DoD contracted with Novavax to create “demonstration products”: not actual medical treatments that must comport with regulatory law. (See Warp Speed to Democide for an in-depth dissection of this long running military operation.)
That contract is just one of a series of contracts that Novavax has entered into with the Federal leviathan’s biowarfare agencies:
Novavax has been awarded a contract by the US Department of Defense (DoD) for the manufacturing of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate. JPEO-CRBND-EB, through funding provided by the Defense Health Program, has agreed to fund up to $60 million to support Novavax in its production of several components of the vaccine that will be manufactured in the United States. The agreement includes a 2020 delivery of 10 million doses of NVX-CoV2373 for DoD that could be used in Phase 2/3 clinical trials or under an Emergency Use Authorization (EUA) if approved by the US FDA.
— NovaVax History, Zippia.Com
In early February of 2021, whilst still partnered with the DoD, Novavax entered into contractual agreements with Takeda Pharmaceutical to produce a localized Japanese formulation. Mind you, Takeda Pharmaceutical is the same company that was hit with a recall for “stainless steel” found within the Moderna formulations they produced in 2021. According to Moderna and Takeda’s joint press statement:
“The rare presence of stainless steel particles in the Moderna Covid-19 vaccine does not pose an undue risk to patient safety and it does not adversely affect the benefit/risk profile of the product.”
How these companies can claim it was harmless stainless steel when the very same article states that the substance has yet to be identified is beyond me.
Almost as interesting as this long running dalliance is Novavax’s stock history in the lead up to the COVID PsyOp. Starting on November 27th, 2019 and long predating the official acknowledgment of the mind virus called COVID, Novavax stock started being traded in increasingly significant quantities. There was more trade volume in December 2019 alone than the entire year preceding it. Novavax, Inc.’s stock price nearly doubled during the end of 2019, going from $3.98 in December, to $7.62 at the beginning of the January 2020. By April, the price had increased more than twentyfold to $83.35, hitting a 5 year peak of $238.54 on August 1st, 2021. Since then, their stock price has cratered, now hovering above the pre-plandemic levels at $4.03.
That’s some mighty convenient timing in the lead up to the greatest looting of the middle class by the vampiric banking elite in all of human history.
— NVAX historic stock prices.
For a company that hadn’t brought a product to market in its entire corporate history, Novavax’s COVID injections have sailed through the potemkin regulatory process with ease. On July 20th, 2022, the NIH and BARDA recommended Novavax for all adults 18 years and older. On October 3rd, 2023, Novavax was granted EUA approval (emphasis mine):
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for active immunization to prevent COVID-19 in individuals aged 12 and older. Immediately upon authorization, Novavax’s vaccine has also been included in the recommendations issued by the U.S. Centers for Disease Control and Prevention (CDC) on September 12, 2023.
— Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
Since the Novavax injection is now part of the recommended childhood vaccine schedule, its parent company is legally indemnified from any death, injury or disease it will cause to its victims. The Regime’s Chaff & Countermeasures continue to buy them valuable time as so-called public policy and healthcare “experts” are busy fighting yesterday’s battles.
Novavax has been widely touted as the “the only protein-based non-mRNA COVID vaccine option in the U.S.”.
As you will see, mRNA or not, the tell-tale signs of DARPA’s nanotechnology is present within these injections as well.
For those of you who are new to my work, I highly recommend reading Nanotechnology In The Blood: A Compendium for a crash course on nanotech morphology. As you compare the objects we have found in human blood to what we will see in this sample, note the shocking level of uniformity in the objects found in our blood and the objects found in the injections.
II — Blood Analysis
A. Legend
Graphene Oxide – GO
Graphene Nanocrystals – GNC
Graphene Hydrogel – GHG
Graphene Quantum Dots – GQD
Hydrogel Nanoribbons – HNR
Hydrogel Nanostructure – HNS
B. Preparation & Methodologies
Our sample is an unadulterated droplet from Novavax’s formulation of injectable bioweapons, falsely labeled as so-called “COVID vaccines”. It was kept frozen until we first processed the sample on January 22nd of 2024. This vial was obtained via the same clinic that all of our other bioweapon samples were procured from. This vial was kept at room temperature (~72 °F) for roughly 30 minutes before sampling the vial.
Our glass slides were brand new; they were also sterilized and washed with 99% Isopropyl Alcohol before use. They were dried with Kimtech wipes, and compressed gas was used to blow particulates off the slide & slip cover. The vial was delicately mixed. The solution was drawn with a new, in-package insulin needle and syringe.
C. Sample
Editor’s Note: Images will be referred to by their timestamps going forward.
Precisely like our injected patients’ blood, our uninjected patients’ blood, or the mRNA injections, this sample of Novavax shows the tell-tale and frankly ubiquitous signs of self-assembling nanotechnology. Witness the large quantum nursery in action above, with a highly developed filament extruding from it.
This is clearest example of the many hydrogel structures found in this sample, which I will not reproduce in their entirety for sake of brevity. Note the proliferation of quantum dots in the vicinity of this structure.
Here we can see hydrogel filaments in the beginning stages of construction, with ubiquitous amounts of quantum dots assisting in that process.
These hydrogel filaments are more well developed, but quantum dots can still be seen inside them.
Like the supposedly mRNA containing injections, this non-mRNA variant also contains a frankly staggering amount of hydrogel within it. The pictures above are a truly small sampling of the hydrogel islands found within this sample in various states of sophistication (note the proliferation of quantum dots as well).
Lastly, we have a filament being constructed in between two hydrogel islands. Fortuitously, we have captured almost precisely this same activity within the blood of our first patient in my inaugural essay on this topic.
III – Conclusions
It bears continual repeating: the structures seen in The Forced Evolution of Humanity series and the sample seen above can not be mistaken for bacteria, cysts, dust, cloth fibers, microplastics, natural crystals, parasites, or any other previously known material — either natural or synthetic — capable of infecting human blood.
The convergence of events surrounding the inclusion of nanotechnology in the formulas of three separate pharmaceutical companies (Pfizer/Moderna/Novavax) and the subsequent distribution of tainted batches to a single clinic is not merely a coincidence, but a glaring manifestation of a sinister agenda at play.
To dismiss these occurrences as mere happenstance is an insult to both reason and intellect.
The statistical improbability of three distinct companies independently incorporating nanotech into their products, only to have those same products find their way to a singular medical facility, is far, far beyond the realm of simple chance. Such an occurrence defies both the laws of probability and stretches the limits of credulity beyond their breaking point.
Consider, if you will, the intricate web of logistics and manufacturing processes involved in the production and distribution of pharmaceuticals via Operation Warp Speed. Each step, from formulation to packaging to shipping, is meticulously planned and executed with precision. The notion that three separate entities could all unwittingly introduce nanotechnology into their products without collusion or malice strains the boundaries of plausibility.
Moreover, the fact that these tainted batches all found their way to a single clinic is a damning indictment of the regulatory system governing American pharmaceuticals. Are we to believe that no safeguards were in place to prevent such a catastrophic breach of trust? Are we to accept, without question, that the well-being of patients was merely sacrificed on the altar of corporate greed and negligence? It is abundantly clear that something exceedingly nefarious is afoot and simple greed or incompetence can not explain this coordinated assault. Whether it be the forced evolution of humanity into transhuman abominations, the deliberate mass poisoning of the world, or a malevolent plot to control human fertility, the implications are chilling. We can not afford to turn a blind eye to such flagrant abuses of power for much longer.
Furthermore, the surreptitious inclusion of nanotechnology in a vast swathe of our pharmaceuticals raises a host of ethical and moral concerns. Nanoparticles, by their very nature, possess the ability to interact with biological systems in unpredictable ways. The long-term effects of their ingestion or absorption into the human body are largely unknown, yet we are expected to swallow these pills and potions without question or hesitation.
In the pursuit of profit and technological advancement, we have forsaken the principles of prudence and caution.
It is a Faustian bargain that threatens to unravel the very fabric of our civilization.
Now more than ever, please continue to spread this vital information to as many people as you can, and be sure to subscribe to keep up to date on our latest findings and research. All of the information and articles on this publication will remain free of charge in perpetuity.
“Operation Warp Speed is creating a portfolio of vaccines to increase the odds that we will have at least one SAFE, EFFECTIVE vaccine as soon as the end of this year.
Depending on success in clinical trials, today’s $1.6 billion investment supports our latest vaccine candidate, being developed by Novavax, all the way through clinical trials and manufacturing 100 million doses for the American people.”
— Trump HHS Secretary Alex Azar, Former President of Lilly USA, LLC
Further Research
The Ebola “Virus”, Part I by Viroliegy
